VEGFA and COVID-19: Thus, it has been suggested by a few studies that anti-VEGF therapy could be beneficial in treating severe COVID-19 and various clinical trials are still ongoing (Islam et al., 2020; Pang et al., 2021; Patel et al., 2021; Blumberg et al., 2022; Fanning et al., 2022; ClinicalTrials.gov, 2024a; ClinicalTrials.gov, 2024b; ClinicalTrials.gov, 2024c; ClinicalTrials.gov, 2024d; ClinicalTrials.gov, 2024e).